PetMed Express, Inc. (PETS) — 分析摘要
PetMed Express, Inc.（PETS）的市值为27.32百万美元，最近一年的营收同比增长了-21.1%。净利润率为-32.0%。当前市盈率为-0.9倍。
核心要点
- 营收同比变化-21.1%
- 净利润率-32.0%
- 市盈率-0.9倍
与RETAIL-DRUG STORES AND PROPRIETARY STORES板块的其他公司相比，PETS的营收增长为-21.1%，市盈率为-0.9倍。
PetMed Express, Inc. (PETS)
前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
流动比率为 0.68x — 流动负债超过流动资产
营业利润率为 -18.2% — 经营亏损显著
最新报表显示自由现金流为负。
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
行业
RETAIL-DRUG STORES AND PROPRIETARY STORES
员工人数
189
总部
DELRAY BEACH, FL
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$1.20
股息收益率
95.24%
股息历史
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。